3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Fallopian Tube Neoplasms
4
Ovarian Neoplasms
3
Triple Negative Breast Neoplasms
2
Breast Neoplasms
2
Solitary Fibrous Tumor, Pleural
1
Small Cell Lung Carcinoma
1
Prostatic Neoplasms
1
Neoplasm Metastasis
1
Mesothelioma, Malignant
1
Melanoma
1
Fallopian Tube Mucinous Adenocarcinoma
1
Colorectal Neoplasms
1
Carcinosarcoma
1
Carcinoma, Non-Small-Cell Lung
1
Carcinoma, Endometrioid
1
Interventions
Gemcitabine
15
Cisplatin
13
durvalumab
10
pembrolizumab
9
Oxaliplatin
8
Magnetic Resonance Spectroscopy
8
Specimen Handling
6
Leucovorin
6
Biopsy
6
Fluorouracil
5
Paclitaxel
4
Folfox protocol
4
Taxes
3
Radiation
3
Nivolumab
3
Irinotecan
3
Immunoglobulin G
3
Disulfides
3
tislelizumab
2
pemigatinib
2
olaparib
2
futibatinib
2
fludarabine
2
dehydroftorafur
2
Platinum
2
Liver Transplantation
2
Fluorodeoxyglucose F18
2
Floxuridine
2
Dexamethasone
2
Carboplatin
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Cholangiocarcinoma
×
cediranib
×
90 days
×
Clear all
No trials found.